Know the enemy and know yourself: Addressing cryptic fungal pathogens of humans and beyond
Jacob L. Steenwyk,Antonis Rokas,Gustavo H. Goldman
DOI: https://doi.org/10.1371/journal.ppat.1011704
IF: 7.464
2023-10-20
PLoS Pathogens
Abstract:Accurate diagnosis is a key first step to mitigating the burden of fungal pathogens. Traditional diagnosis methods use microscopy, histopathology, culturing, and MALDI-TOF [8]. Although helpful, these methods often lack specificity, especially for cryptic pathogens. Molecular typing—such as phylogenetic analysis of one or a few loci—has proven more accurate and brought cryptic pathogens to light [3,6]. However, few loci can, at times, lack insufficient information for accurate species determination. For example, Aspergillus latus— a cryptic pathogen and allodiploid hybrid that originated from a fusion event between A . spinulosporus and a close relative of A . quadrilineatus , two species that are closely related to A . nidulans— has gone largely undetected in the clinical setting due to the shortcomings of a single-locus typing in a hybrid genome [4]. Population genome sequencing and extensive phenotyping has revealed diagnostics for robust identification of A . latus , such as a large genome size, which can be detected using genome sequencing, fluorescence-activated cell sorting, or measuring conidia sizes [9]. Other genome-scale approaches can overcome the insufficient information in molecular typing of one or a few loci. For example, data-rich phylogenomics has revealed instances of misidentified human and plant pathogens in the genus Aspergillus [10]. The greater specificity of phylogenomics comes with the drawbacks of requiring more expertise (i.e., knowledge of processing and analysis of genomic data), resources (e.g., sequencing and computational resources), and time. In the clinical setting, rapid and cost-effective diagnosis is critical for lowering mortality rates [8]. An unexplored genome-scale alternative approach ripe for application to fungi is average nucleotide identity. This and similar alternative approaches could be coupled to (semi)automated genome sequencing, assembly, and analysis infrastructure, powered by robotics and cloud computing. Comparative analysis of diverse methods for diagnosing fungal infections will elucidate the most efficacious method, or combination thereof, for faithful diagnostics. Beyond identification, examining phenotypic profiles among pathogens will elucidate other key aspects of pathogen biology relevant to combatting and preventing disease. This is particularly true for cryptic fungal pathogens whose phenotypic profiles remain largely unknown, and numerous examples have revealed cryptic fungal pathogens have distinct drug resistance profiles compared to close relatives [4–6]. For example, the cryptic pathogen A . latus is substantially more drug resistant to caspofungin than reference isolates of A . nidulans [9]. Considering strain heterogeneity—phenotypic variation within a species, including variation in virulence and resistance to antifungal drugs—has emerged as an important consideration when studying microbial pathogenicity [4,9].
microbiology,virology,parasitology